68 related articles for article (PubMed ID: 24088131)
1. Long-term effects of ABCB1 and SXR SNPs on the systemic exposure to cyclosporine in pediatric kidney transplant patients.
Ferraresso M; Belingheri M; Turolo S; Ghio L; Tirelli AS; Grillo P; Lepore M; Edefonti A
Pharmacogenomics; 2013 Oct; 14(13):1605-13. PubMed ID: 24088131
[TBL] [Abstract][Full Text] [Related]
2. Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study.
Llaudó I; Colom H; Giménez-Bonafé P; Torras J; Caldés A; Sarrias M; Cruzado JM; Oppenheimer F; Sánchez-Plumed J; Gentil MÁ; Ekberg H; Grinyó JM; Lloberas N
Transpl Int; 2013 Feb; 26(2):177-86. PubMed ID: 23216707
[TBL] [Abstract][Full Text] [Related]
3. The potential of steroids and xenobiotic receptor polymorphisms in forecasting cyclosporine pharmacokinetic variability in young kidney transplant recipients.
Ferraresso M; Turolo S; Belinghieri M; Tirelli AS; Grillo P; Groppali E; Edefonti A; Ghio L
Pediatr Transplant; 2012 Sep; 16(6):658-63. PubMed ID: 22765024
[TBL] [Abstract][Full Text] [Related]
4. Associations of ABCB1, NFKB1, CYP3A, and NR1I2 polymorphisms with cyclosporine trough concentrations in Chinese renal transplant recipients.
Zhang Y; Li JL; Fu Q; Wang XD; Liu LS; Wang CX; Xie W; Chen ZJ; Shu WY; Huang M
Acta Pharmacol Sin; 2013 Apr; 34(4):555-60. PubMed ID: 23503472
[TBL] [Abstract][Full Text] [Related]
5. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation.
Anglicheau D; Thervet E; Etienne I; Hurault De Ligny B; Le Meur Y; Touchard G; Büchler M; Laurent-Puig P; Tregouet D; Beaune P; Daly A; Legendre C; Marquet P
Clin Pharmacol Ther; 2004 May; 75(5):422-33. PubMed ID: 15116055
[TBL] [Abstract][Full Text] [Related]
6. The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients.
Akbas SH; Bilgen T; Keser I; Tuncer M; Yucetin L; Tosun O; Gultekin M; Luleci G
Transplant Proc; 2006 Jun; 38(5):1290-2. PubMed ID: 16797284
[TBL] [Abstract][Full Text] [Related]
7. Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation.
Yanagimachi M; Naruto T; Tanoshima R; Kato H; Yokosuka T; Kajiwara R; Fujii H; Tanaka F; Goto H; Yagihashi T; Kosaki K; Yokota S
Clin Transplant; 2010; 24(6):855-61. PubMed ID: 20030680
[TBL] [Abstract][Full Text] [Related]
8. ABCB1 G2677 allele is associated with high dose requirement of cyclosporin A to prevent renal allograft rejection in North India.
Singh R; Kesarwani P; Srivastava A; Mittal RD
Arch Med Res; 2008 Oct; 39(7):695-701. PubMed ID: 18760199
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of multidrug resistance gene (MDR1) and cyclosporine absorption in de novo renal transplant patients.
Foote CJ; Greer W; Kiberd B; Fraser A; Lawen J; Nashan B; Belitsky P
Transplantation; 2007 May; 83(10):1380-4. PubMed ID: 17519790
[TBL] [Abstract][Full Text] [Related]
10. MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.
Foote CJ; Greer W; Kiberd BA; Fraser A; Lawen J; Nashan B; Belitsky P
Transplant Proc; 2006 Nov; 38(9):2847-9. PubMed ID: 17112845
[TBL] [Abstract][Full Text] [Related]
11. The effect of ABCB1 C3435T polymorphism on pharmacokinetics of tacrolimus in liver transplantation: a meta-analysis.
Liu YY; Li C; Cui Z; Fu X; Zhang S; Fan LL; Ma J; Li G
Gene; 2013 Dec; 531(2):476-88. PubMed ID: 24042126
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients.
Santoro A; Felipe CR; Tedesco-Silva H; Medina-Pestana JO; Struchiner CJ; Ojopi EB; Suarez-Kurtz G
Pharmacogenomics; 2011 Sep; 12(9):1293-303. PubMed ID: 21806386
[TBL] [Abstract][Full Text] [Related]
13. Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients.
Falck P; Asberg A; Byberg KT; Bremer S; Bergan S; Reubsaet JL; Midtvedt K
Transplantation; 2008 Nov; 86(10):1379-83. PubMed ID: 19034006
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic study of ABCB1 and CYP3A5 genes during the first year following heart transplantation regarding tacrolimus or cyclosporine levels.
Jordán de Luna C; Herrero Cervera MJ; Sánchez Lázaro I; Almenar Bonet L; Poveda Andrés JL; Aliño Pellicer SF
Transplant Proc; 2011; 43(6):2241-3. PubMed ID: 21839244
[TBL] [Abstract][Full Text] [Related]
15. Do drug transporter (ABCB1) SNPs influence cyclosporine and tacrolimus dose requirements and renal allograft outcome in the posttransplantation period?
Singh R; Srivastava A; Kapoor R; Mittal RD
J Clin Pharmacol; 2011 Apr; 51(4):603-15. PubMed ID: 20571034
[TBL] [Abstract][Full Text] [Related]
16. Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients.
Crettol S; Venetz JP; Fontana M; Aubert JD; Ansermot N; Fathi M; Pascual M; Eap CB
Pharmacogenet Genomics; 2008 Apr; 18(4):307-15. PubMed ID: 18334915
[TBL] [Abstract][Full Text] [Related]
17. The Effect of ABCB1 C3435T Polymorphism on Cyclosporine Dose Requirements in Kidney Transplant Recipients: A Meta-Analysis.
Lee J; Wang R; Yang Y; Lu X; Zhang X; Wang L; Lou Y
Basic Clin Pharmacol Toxicol; 2015 Aug; 117(2):117-25. PubMed ID: 25536375
[TBL] [Abstract][Full Text] [Related]
18. Associations between common variants in the MDR1 (ABCB1) gene and ulcerative colitis among North Indians.
Juyal G; Midha V; Amre D; Sood A; Seidman E; Thelma BK
Pharmacogenet Genomics; 2009 Jan; 19(1):77-85. PubMed ID: 19005421
[TBL] [Abstract][Full Text] [Related]
19. Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients.
Bandur S; Petrasek J; Hribova P; Novotna E; Brabcova I; Viklicky O
Transplantation; 2008 Nov; 86(9):1206-13. PubMed ID: 19005401
[TBL] [Abstract][Full Text] [Related]
20. CYP3A5 polymorphism effect on cyclosporine pharmacokinetics in living donor renal transplant recipients: analysis by population pharmacokinetics.
Song J; Kim MG; Choi B; Han NY; Yun HY; Yoon JH; Oh JM
Ann Pharmacother; 2012 Sep; 46(9):1141-51. PubMed ID: 22947591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]